Open Beta
TREN
MetriLume
TREN

US marketsAORT

SEC-sourced researchBeta

AORT

ARTIVION, INC.

Company comparison ↗

Data passport

CIK
0000784199
Exchange
NYSE
Business activity
Surgical & Medical Instruments & Apparatus · SIC 3841
Financial inputs
6/6
Filing date
Sep 11, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 354,004,000.0000 USD; December 2024: 388,537,000.0000 USD; December 2025: 441,330,000.0000 USD441.3M USD0 USD0December 2023December 2024December 2025
AORT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023354,004,000.0000Feb 18, 2026
December 2024388,537,000.0000Feb 18, 2026
December 2025441,330,000.0000Feb 18, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025441,330,000.00009,768,000.000039,880,000.0000884,796,000.0000436,564,000.0000Feb 18, 2026
December 2024388,537,000.0000-13,359,000.000022,236,000.0000789,101,000.0000512,901,000.0000Feb 18, 2026
December 2023354,004,000.0000-30,690,000.000018,825,000.0000——Feb 18, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

67/100
Profitability54
Growth64
Balance sheet51
Cash generation68
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$441.33MJan 1, 2025 – Dec 31, 2025Feb 18, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$388.54MJan 1, 2024 – Dec 31, 2024Feb 18, 202610-K
Net incomeNetIncomeLoss$9.77MJan 1, 2025 – Dec 31, 2025Feb 18, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$39.88MJan 1, 2025 – Dec 31, 2025Feb 18, 202610-K
Total assetsAssets$884.8MDec 31, 2025Feb 18, 202610-K
Total liabilitiesLiabilities$436.56MDec 31, 2025Feb 18, 202610-K

New filings

Explore methodology ↗